FDA Grants Early Access to Breakthrough Pancreatic Cancer Drug
The US FDA approves expanded access to daraxonrasib, an innovative pancreatic cancer drug, offering new hope for patients facing one of the deadliest forms of cancer.
The US FDA approves expanded access to daraxonrasib, an innovative pancreatic cancer drug, offering new hope for patients facing one of the deadliest forms of cancer.
Scientists have developed a new handheld tuberculosis diagnostic tool that delivers lab-level accuracy in under 30 minutes without requiring sputum samples — a breakthrough that could benefit millions of TB patients worldwide.
MIT researchers have developed a self-organizing pencil beam laser technology that converts chaotic laser light into a high-precision brain imaging tool, opening new pathways for targeted neurological disease treatment.
A pancreatic cancer mRNA vaccine has demonstrated lasting therapeutic effects in an early clinical trial, described by National Geographic as ’the biggest breakthrough in pancreatic cancer treatment in decades.'